Archived Content

The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.

Vaccines, Blood & Biologics

6/29/2007 Fax 2 - Voluven


Division of Blood Applications
1401 Rockville Pike, Suite 400N, HFM-380
Rockville, Maryland 20852-1448

FAX (301) 827-2857
TEL (301) 827-3524

FAX No. 919-881-0014
To:   W. Gerald Coln, Carolina Research on behalf of Fresenius Kabi

This Fax is regarding STN: BN070012/0 that was submitted to the agency on1-March-07 as an NDA for your Voluven product. The reviewers for this application request Fresenius KAbi to amend the submission by doing the following:

1) Please submit a copy of BB-MF-----, Type II Master File for "Hydroxyethyl Starch 130/0.4 for Injection" for the facilities and equipment. BB-MF ----- is referenced in Module 3.

2) Please submit additional information for the Certificates for the Biological Indicators (BI) (section 3.2.P.3.5.2) used in the sterilization process validation studies N 1986 and N 1989.

Please submit a response to this information request as an amendment to the file by COB 01-August 2007. If we do not receive the information by this date, a complete response letter will be issued that will contain the same items enumerated above.

If you need clarification please call me at 301-827-6165


Franklin T. Stephenson
Regulatory Project Manager

Information provided by: F. Stephenson     Date: June 29, 2007 2:45:01 PM

Approved by J. Kim   Date June 29, 2007   Transmitted by F. Stephenson   Date: 6/29/2007

Page Last Updated: 02/21/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English